HEXO Corp. (T:HEXO*CA)

Business Focus: Alternative Medicine

Sector:  Healthcare Industry:  Pharmaceuticals
 
See Regulatory Filings on SEDAR
Company Contact
Address: 3000 SOLANDT ROAD
OTTAWA ON K2K 2X2
Tel: N/A
Website: https://www.hexocorp.com
IR: See website
<
Key People
Michael R. Munzar
Independent Chairman of the Board
Sebastien St-Louis
President, Chief Executive Officer, Director
Stephen Burwash
Chief Financial Officer
Donald Courtney
Chief Operating Officer
Dominique Jones
Chief People Officer
Roch Vaillancourt
General Counsel
Veronique Hamel
Chief Innovation Officer
   
Business Overview
Hexo Corp, formerly Hydropothecary Corp, is a Canada-based company that creates and distributes products to serve the Canadian cannabis market. The Company operates with an approximately 300,000 square feet of production capacity. The Company serves the adult-use market under the HEXO brand, while it serves its medical cannabis clients through the Hydropothecary brand. The following are the Company's products under the Hydropothecary brand: Time of Day product line, which includes dried marijuana buds for morning, midday, after dinner and bedtime; Hydrogen (H2) classical medical marijuana line, which includes Papaya Grove, Green Chai and Kush dried marijuana buds, among others; Decarb ready to consume activated marijuana powder; Elixir cannabis oil sublingual spray, as well as Fleur de Lune intimate cannabis oil.
Financial Overview
For the nine months ended 30 April 2020, Hexo Corp revenues increased 67% to C$53.6M. Net loss increased from C$24.9M to C$377.9M. Revenues reflect Revenue from sale of goods increase of 91% to C$74M. Higher net loss reflects Realized fair value amounts on inventory increase from C$9.1M to C$21.4M (expense), Unrealized gain on changes in fair value decrease of 36% to C$21.4M (income).
Reporting Currency: Canadian Dollars
Enterprise value: $320.42M as of Apr 30, 2020
Annual revenue (TTM): $69.06M as of Apr 30, 2020
EBITDA (TTM): -$100.56M as of Apr 30, 2020
Net annual income (TTM): -$422.63M as of Apr 30, 2020
Free cash flow (TTM): -$308.49M as of Apr 30, 2020
Net Debt Last Fiscal Year: $14.08M as of Apr 30, 2020
Shares outstanding: 463,641,833 as of Jul 16, 2020
TTM: Trailing Twelve Months
EBITDA: Earnings Before Interest, Taxes, Depreciation, & Amortization

Thank you for visiting InsiderTracking.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you wish to consider using a browser that blocks ads, please subscribe. Our packages start at $1.00 plus tax for the first month.

Alternatively, if you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). If you are in private browsing mode and do not want to subscribe, please disable tracking protection while visiting our website.

Thank you for using Insider Tracking.